Development of an international standard set of outcome measures for patients with venous thromboembolism : an International Consortium for Health Outcomes Measurement consensus recommendation
Copyright © 2022 Elsevier Ltd. All rights reserved..
The International Consortium for Health Outcomes Measurement assembled an international working group of venous thromboembolism experts and patient representatives to develop a standardised minimum set of outcomes and outcome measurements for integration into clinical practice and potentially research to support clinical decision making and benchmarking of quality of care. 15 core outcomes important to patients and health-care professionals were selected and categorised into four domains: patient-reported outcomes, long term consequences of the disease, disease-specific complications, and treatment-related complications. The outcomes and outcome measures were designed to apply to all patients with venous thromboembolism aged 16 years or older. A measurement tool package was selected for inclusion in the core standard set, with a minimum number of items to be measured at predefined timepoints, which capture all core outcomes. Additional measures can be introduced to the user by a cascade opt-in system that allows for further assessment if required. This set of outcomes and measurement tools will facilitate the implementation of the use of patient-centred outcomes in daily practice.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
The Lancet. Haematology - 9(2022), 9 vom: 01. Sept., Seite e698-e706 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 07.09.2022 Date Revised 07.09.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/S2352-3026(22)00215-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM345725670 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM345725670 | ||
| 003 | DE-627 | ||
| 005 | 20231226025727.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S2352-3026(22)00215-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1152.xml |
| 035 | |a (DE-627)NLM345725670 | ||
| 035 | |a (NLM)36055334 | ||
| 035 | |a (PII)S2352-3026(22)00215-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gwozdz, Adam M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Development of an international standard set of outcome measures for patients with venous thromboembolism |b an International Consortium for Health Outcomes Measurement consensus recommendation |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.09.2022 | ||
| 500 | |a Date Revised 07.09.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier Ltd. All rights reserved. | ||
| 520 | |a The International Consortium for Health Outcomes Measurement assembled an international working group of venous thromboembolism experts and patient representatives to develop a standardised minimum set of outcomes and outcome measurements for integration into clinical practice and potentially research to support clinical decision making and benchmarking of quality of care. 15 core outcomes important to patients and health-care professionals were selected and categorised into four domains: patient-reported outcomes, long term consequences of the disease, disease-specific complications, and treatment-related complications. The outcomes and outcome measures were designed to apply to all patients with venous thromboembolism aged 16 years or older. A measurement tool package was selected for inclusion in the core standard set, with a minimum number of items to be measured at predefined timepoints, which capture all core outcomes. Additional measures can be introduced to the user by a cascade opt-in system that allows for further assessment if required. This set of outcomes and measurement tools will facilitate the implementation of the use of patient-centred outcomes in daily practice | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a de Jong, Cindy M M |e verfasserin |4 aut | |
| 700 | 1 | |a Fialho, Luz Sousa |e verfasserin |4 aut | |
| 700 | 1 | |a Likitabhorn, Theerawich |e verfasserin |4 aut | |
| 700 | 1 | |a Sossi, Frieda |e verfasserin |4 aut | |
| 700 | 1 | |a Jaber, Paula Blancarte |e verfasserin |4 aut | |
| 700 | 1 | |a Højen, Anette Arbjerg |e verfasserin |4 aut | |
| 700 | 1 | |a Arcelus, Juan I |e verfasserin |4 aut | |
| 700 | 1 | |a Auger, William R |e verfasserin |4 aut | |
| 700 | 1 | |a Ay, Cihan |e verfasserin |4 aut | |
| 700 | 1 | |a Barco, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Gazzana, Marcelo B |e verfasserin |4 aut | |
| 700 | 1 | |a Bayley, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Bertoletti, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Cate-Hoek, Arina Ten |e verfasserin |4 aut | |
| 700 | 1 | |a Cohen, Alexander T |e verfasserin |4 aut | |
| 700 | 1 | |a Connors, Jean M |e verfasserin |4 aut | |
| 700 | 1 | |a Galanaud, Jean-Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Labropoulos, Nicos |e verfasserin |4 aut | |
| 700 | 1 | |a Langlois, Nicole |e verfasserin |4 aut | |
| 700 | 1 | |a Meissner, Mark H |e verfasserin |4 aut | |
| 700 | 1 | |a Noble, Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Nossent, Esther J |e verfasserin |4 aut | |
| 700 | 1 | |a de León Lovatón, Paula Ponce |e verfasserin |4 aut | |
| 700 | 1 | |a Robert-Ebadi, Helia |e verfasserin |4 aut | |
| 700 | 1 | |a Rosovsky, Rachel P |e verfasserin |4 aut | |
| 700 | 1 | |a Smolenaars, Noa |e verfasserin |4 aut | |
| 700 | 1 | |a Toshner, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Tromeur, Cécile |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Kang-Ling |e verfasserin |4 aut | |
| 700 | 1 | |a Westerlund, Eli |e verfasserin |4 aut | |
| 700 | 1 | |a de Wit, Kerstin |e verfasserin |4 aut | |
| 700 | 1 | |a Black, Stephen A |e verfasserin |4 aut | |
| 700 | 1 | |a Klok, Frederikus A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet. Haematology |d 2014 |g 9(2022), 9 vom: 01. Sept., Seite e698-e706 |w (DE-627)NLM244793018 |x 2352-3026 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2022 |g number:9 |g day:01 |g month:09 |g pages:e698-e706 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S2352-3026(22)00215-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2022 |e 9 |b 01 |c 09 |h e698-e706 | ||